Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, USA.
Nat Rev Clin Oncol. 2020 Nov;17(11):655-656. doi: 10.1038/s41571-020-0420-0.
Measuring the methylation status of cell-free DNA (cfDNA) in plasma holds great potential for the early, noninvasive detection of cancer. Two recent papers published in Nature Medicine showcase the successful application of cfDNA methylation- based cancer detection to two highly challenging scenarios.
检测血浆中游离 DNA(cfDNA)的甲基化状态在癌症的早期、非侵入性检测方面具有巨大的潜力。最近在《自然医学》杂志上发表的两篇论文展示了基于 cfDNA 甲基化的癌症检测在两种极具挑战性的情况下的成功应用。